Toggle navigation
Home
Search
Services
Blog
Contact
About
Optimal Synthesis of Benzodiazepine Glucuronides
Gu, Xue-Qin
Synthetic Technology Corporation, Inc., Honolulu, HI, United States
Search 4 grants from Xue-Qin Gu
Search grants from Synthetic Technology Corporation, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Research Education Component (REC)
Actg 219 - Pediatric HIV Late Outcomes Protocol
Gram Negative Enteric Pathogens and Autoimmunity
Diabetes Prevention Trial 1 (Dpt 1)
Core - Oligonucleotide Synthesis Facility
Recently added grants:
Targeting histone deacetylase 3 for chronic kidney disease
BLR&D Research Career Development Transition Award Application
Opioid Support and Risk Reduction Online Platform
Regulation of pancreatitis severity
Mechanisms of Renal Cell Injury
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44DA008490-03
Application #
2120985
Study Section
Special Emphasis Panel (ZRG7-SSS-W (05))
Project Start
1995-07-01
Project End
1997-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Synthetic Technology Corporation, Inc.
Department
Type
DUNS #
City
Honolulu
State
HI
Country
United States
Zip Code
96816
Related projects
NIH 1996
R44 DA
Optimal Synthesis of Benzodiazepine Glucuronides
Gu, Xue-Qin / Synthetic Technology Corporation, Inc.
NIH 1995
R44 DA
Optimal Synthesis of Benzodiazepine Glucuronides
Gu, Xue-Qin / Synthetic Technology Corporation, Inc.
Comments
Be the first to comment on this grant